Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine
2015 · The European Journal of Health Economics · 23 citations
https://doi.org/10.1007/s10198-015-0673-1
W
W. Dunlop
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
818
Citations
17
h-index
24
i10-index
W. Dunlop is an academic researcher from AstraZeneca (United Kingdom). The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Opioid Use Disorder Treatment & Pain Management and Opioid Use. The author has an h-index of 17, co-authored 66 publications.
ORCID: 0000-0002-9794-8978Papers by this author
worksPatient Reported Burden of Asthma on Resource Use and Productivity Across 11 Countries in Europe
2015 · Advances in Therapy · 17 citations
https://doi.org/10.1007/s12325-015-0204-6
When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development
2017 · Advances in Therapy · 16 citations
https://doi.org/10.1007/s12325-017-0567-y
BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles
2016 · PharmacoEconomics · 11 citations
https://doi.org/10.1007/s40273-016-0427-7
CO7 Progression-Free Survival As a Surrogate for Overall Survival in Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer: A Targeted Literature Review
2024 · Value in Health · 1 citations
https://doi.org/10.1016/j.jval.2024.10.084
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5195428
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat